Migraine-like headache attributed to a causative disorder: primary migraine or secondary headache with a migraine-like phenotype?
Our study supports the ICHD-3 statement that migraine-like headache attributed to a secondary cause should be coded as a secondary headache of the migraine type and that it is a migraine mimic attributed to a causative disorder.
Authors
- Rigmor Jensen (ORCID: https://orcid.org/0000-0001-6433-5887)
- Todd J. Schwedt (ORCID: https://orcid.org/0000-0002-7780-7086)
- Denis V. Gilev (ORCID: https://orcid.org/0000-0003-1040-5696)
- Catherine D. Chong (ORCID: https://orcid.org/0000-0002-9035-8748)
- Nadja Skadkær Hansen (ORCID: https://orcid.org/0000-0002-5488-7992)
- Jes Olesen (ORCID: https://orcid.org/0000-0002-6712-2702)
- Elena R. Lebedeva (ORCID: https://orcid.org/0000-0003-2463-7113)
- Henrik Winther Schytz (ORCID: https://orcid.org/0000-0002-6262-2986)
Institutions
- University of Copenhagen (DK)
- Ural Federal University (RU)
- Ural State Medical University (RU)
- Mayo Clinic Hospital (US)
- Institute of International Relations (RU)
Publication Details
- Journal
- The Journal of Headache and Pain
- Published
- 2025-10-23
- DOI
- https://doi.org/10.1186/s10194-025-02152-7
- Citations
- 1
- Primary Topic
- Migraine and Headache Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.47
Funders
- U.S. Department of Defense
- American Heart Association
- Eli Lilly and Company
- Pfizer
- Patient-Centered Outcomes Research Institute
- Teva Pharmaceutical Industries
- Lundbeckfonden
- Novo Nordisk
- Rigshospitalet
- TrygFonden
- H. Lundbeck A/S
- National Institutes of Health